← Signals · Technology · TSXV
$PVT
Pivotree Inc.
Signal as of N/A  ·  90-day rolling window  ·  Software & IT Services
Confluence Score
—
out of 100  ·  Full breakdown →
Score delayed 7 days on Free  ·  See today's score — Analyst →
Signals scoring 20–39 have historically hit 47% of the time (avg +6.8% over 90 days, 105 backtested signals). Methodology →
🔒 Risk monitoring — insider-selling & reversal warnings (Analyst)
No insider transactions in window Lobbying: 0 regs  ·  Contracts: 0 wins
Confluence Score
—
Unlock breakdown →
Insider Activity (90d)
0
0 buyers  ·  —  ·  open-market only
Current Price
$1.39
CAD  ·  5-min cache
Market Cap
$37M
CAD  ·  TMX
Lobbying & Contracts
None
0 regs  ·  0 contracts
Technology on Form55: 53% hit rate · -6.0% alpha vs XIU.TO · 19 closed signals Track Record →
★
Signal Analyst
The Confluence Score and insider trade feed above are free. Signal Analyst adds the full component breakdown, lobbying registrations, and contract wins — plus alerts when this company's signal moves, so you don't have to keep checking back.
Monitor — CAD $29/mo
Price Chart
12 months daily  ·  TSXV:PVT
Insider Transactions
90-day window  ·  50 filings
Date Insider Role Nature Dir. Shares Buy Price Return Value
Jul 01, 2026 Farquhar, James Joel Thomas — Other Sell — — — —
Jul 01, 2026 Farquhar, James Joel Thomas — Other Sell — — — —
Jul 01, 2026 Farquhar, James Joel Thomas — Other Sell — — — —
Jul 01, 2026 Farquhar, James Joel Thomas — Other Sell — — — —
Jul 01, 2026 Farquhar, James Joel Thomas — Other Sell — — — —
Jun 30, 2026 Jurkuta, Ted Christopher — Exercise Sell 3,107 — — —
Jun 30, 2026 Ashoor, Moataz — Exercise Sell 2,437 — — —
Jun 30, 2026 Isaacson, Clifford Charles — Exercise Sell 2,771 — — —
Jun 30, 2026 Ashoor, Moataz — Exercise Buy 2,437 — — —
Jun 30, 2026 Ashoor, Moataz — Exercise Buy 2,437 — — —
Jun 30, 2026 Jurkuta, Ted Christopher — Exercise Buy 3,107 — — —
Jun 30, 2026 Aranha, Edgar Mervyn — Exercise Buy 2,347 — — —
Jun 30, 2026 Jurkuta, Ted Christopher — Exercise Buy 3,107 — — —
Jun 30, 2026 Aranha, Edgar Mervyn — Exercise Sell 2,347 — — —
Jun 30, 2026 Aranha, Edgar Mervyn — Exercise Sell 2,347 — — —
Jun 30, 2026 Aranha, Edgar Mervyn — Exercise Buy 2,347 — — —
Jun 30, 2026 Metcalf, Kyle — Exercise Sell 2,582 — — —
Jun 30, 2026 Metcalf, Kyle — Exercise Buy 2,582 — — —
Jun 30, 2026 Di Nardo, William — Exercise Sell 5,310 — — —
Jun 30, 2026 Di Nardo, William — Exercise Buy 5,310 — — —
Jun 30, 2026 Joyce, Sarah Katherine — Exercise Sell 59,054 — — —
Jun 30, 2026 Aldridge, Ellen Ashlee — Exercise Sell 94,517 — — —
Jun 30, 2026 Isaacson, Clifford Charles — Exercise Sell 30,881 — — —
Jun 30, 2026 Isaacson, Clifford Charles — Exercise Sell 2,771 — — —
Jun 30, 2026 Isaacson, Clifford Charles — Exercise Buy 33,652 — — —
Jun 30, 2026 Isaacson, Clifford Charles — Exercise Buy 33,652 — — —
Jun 30, 2026 Isaacson, Clifford Charles — Exercise Sell 30,881 — — —
Jun 26, 2026 Morris, William Frederick — Comp. Grant Buy 33,903 — — —
Jun 26, 2026 Lobo, Vernon — Comp. Grant Buy 67,807 — — —
Jun 26, 2026 Beattie, Brian Robert — Comp. Grant Buy 33,903 — — —
Jun 26, 2026 Bryan, Scott — Comp. Grant Buy 24,657 — — —
Jun 26, 2026 Pivotree Inc. — Buyback Buy 4,700 $1.40 -0.7%  · 16d $7K
Jun 25, 2026 Pivotree Inc. — Buyback Buy 300 $1.40 -0.7%  · 17d $420
Jun 24, 2026 Pivotree Inc. — Buyback Buy 1,300 $1.40 -0.7%  · 18d $2K
Jun 23, 2026 Pivotree Inc. — Buyback Buy 21,400 $1.40 -0.7%  · 19d $30K
May 14, 2026 Pivotree Inc. — Buyback Buy 200 $1.60 -13.1%  · 59d $320
May 13, 2026 Pivotree Inc. — Buyback Buy 1,500 $1.60 -13.1%  · 60d $2K
May 12, 2026 Pivotree Inc. — Buyback Buy 11,100 $1.60 -13.1%  · 61d $18K
May 11, 2026 Pivotree Inc. — Buyback Buy 3,300 $1.63 -14.9%  · 62d $5K
May 08, 2026 Pivotree Inc. — Buyback Buy 1,500 $1.63 -14.7%  · 65d $2K
May 06, 2026 Pivotree Inc. — Buyback Buy 300 $1.65 -15.8%  · 67d $495
May 06, 2026 Meneley, Patrick Brennan — Buyback Buy 2,839 — — —
May 06, 2026 Meneley, Patrick Brennan — Exercise Sell 15,666 — — —
May 05, 2026 Pivotree Inc. — Buyback Buy 10,100 $1.65 -15.8%  · 68d $17K
May 04, 2026 Pivotree Inc. — Buyback Buy 11,100 $1.68 -17.3%  · 69d $19K
May 01, 2026 Pivotree Inc. — Buyback Buy 900 $1.67 -16.8%  · 72d $2K
Apr 30, 2026 Pivotree Inc. — Buyback Buy 8,100 $1.66 -16.3%  · 73d $13K
Apr 28, 2026 Pivotree Inc. — Buyback Buy 1,600 $1.66 -16.2%  · 75d $3K
Apr 27, 2026 Pivotree Inc. — Buyback Buy 1,300 $1.65 -15.8%  · 76d $2K
Apr 24, 2026 Pivotree Inc. — Buyback Buy 6,300 $1.65 -15.9%  · 79d $10K
Score uses open-market buys only  ·  0 open-market  ·  32 plan / compensation shown but not scored  ·  Return is unrealized, to today's price; a “· Nd” mark means the 90-day window is still open (N of 90 days) — too early to judge.
Score Breakdown
Signal Analyst  ·  $29/mo
Component Points Max Detail Weight
Conviction (unique buyers)  ✓ FREE PREVIEW 0 30 No insider activity
Buy/sell ratio 20 0% buys (0B / 0S)
Dollar value 25 No open-market buys
Lobbying activity 15 None
Contract wins 10 None
Insider track record 10 No track record data
Private placements 8 None
Confluence bonus 10 None
Cluster timing (velocity) 10 No coordinated buying cluster detected
Buy/sell reversal pattern 8 No buy/sell reversal pattern
Total 0 100
Unlock Component Detail — CAD $29/mo
Lobbying Registrations
OCL active  ·  none found
No active OCL lobbying registrations in the last 90 days. Analyst plan →
Government Contract Wins
90-day window  ·  none found
No government contract wins in the last 90 days. Analyst plan →
Private Placements
12 months  ·  Signal Analyst  ·  $29/mo
Private placement history, deal size, and lock-up expiry tracking. Analyst plan →
Indigenous Consultation
no records on file

No Indigenous consultation records on file for PVT.

SEDAR+ Filings
official filing registry
Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →
Short Interest
CIRO  ·  May 15, 2026
Shares short
100
Net change
-200 (-66.7%)
History
May 15: 100
Apr 30: 300
Apr 15: 28,637
Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.